If you don't see your institution, add your dataset to the main dataverse named "RepOD".
Select the dataverse to which you want to add the new dataset:
You need to Sign In/Sign Up to add a dataset.
Share this dataset on your favorite social media networks.
Jankowska, Elżbieta, 2025, "Design and synthesis of proteolytically stable and cell permeable activators of human 20S proteasome and assessing their influence on the enzyme activity in cellular models of neurodegenerative diseases", https://doi.org/10.18150/JEFDSU, RepOD, V1
Learn about Data Citation Standards.
We had identified a new class of peptide-based proteasome activators, inspired by the C-terminal fragment of the Blm10 protein – the yeast equivalent of PA200. An activator called Blm-pep and its analogs strongly stimulated the proteasome. However, they were degraded rapidly in the body and were unable to enter cells. We worked on improving these properties.
We designed peptidomimetics which showed resistance to proteases present in human plasma. The compounds interacted with the human proteasome and possessed the ability to activate it. Their activity was enhanced in comparison to the parent peptides, with the most effective modulators boosting proteasome function up to 10-fold.
We also tested our compounds on proteins directly linked to neurodegenerative diseases: tau (Alzheimer’s disease) and α-synuclein (Parkinson’s disease). The activators accelerated their degradation by the proteasome. By attaching so-called cell-penetrating peptides, we enabled the activators to cross cell membranes and even the blood–brain barrier – a crucial feature for potential therapeutic use.
Further experiments confirmed that the compounds were not cytotoxic and worked not only in test tubes but also inside cells. In a model of mouse neurons mimicking Parkinson’s disease, we demonstrated that our activators effectively promoted the removal of toxic α-synuclein without reducing neuronal survival.
Please consult the Readme.txt file for additional information.
proteasome, activator, peptidomimetics
Trepczyk K, Er S, Hlushchuk I, Airavaara M, Alwani A, Maziarz K, Chmielarz P, Słomska K, Wieczerzak E, Jankowska E. Peptidomimetics Activating the Proteasome: A New Perspective for Parkinson's Treatment. J Med Chem. 2025; 68(8):8967-8979, https://doi.org/10.1021/acs.jmedchem.5c00645 https://doi.org/10.1021/acs.jmedchem.5c00645 doi: 10.1021/acs.jmedchem.5c00645
CC BY - Creative Commons Attribution 4.0
Please select a file or files to be deleted.
The file(s) will be deleted after you click on the Delete button.
Files will not be removed from previously published versions of the dataset.
Please select a file or files to be edited.
For selected file(s) set a license to
Please select a file or files to be downloaded.
Please select a file or files for access request.
Please select restricted file(s) to be unrestricted.
You need to Log In/Sign Up to request access to this file.
Please confirm and/or complete the information needed below in order to continue.
Asterisks indicate required fields
Access to file(s) subject to additional consent under following conditions:
The restricted file(s) selected may not be downloaded because you have not been granted access.
Click Continue to download the files you have access to download.
Are you sure you want to delete this dataset and all of its files? You cannot undelete this dataset.
Are you sure you want to lift the embargo?
Once you lift the embargo, you will not be able to set it again.
Are you sure you want to delete this draft version? Files will be reverted to the most recently published version. You cannot undelete this draft.
Use a Private URL to allow those without Dataverse accounts to access your dataset. For more information about the Private URL feature, please refer to the User Guide.
Private URL has not been created.
Are you sure you want to disable the Private URL? If you have shared the Private URL with others they will no longer be able to use it to access your dataset.
You will not be able to make changes to this dataset while it is in review.
This dataset cannot be published until RepOD is published. Would you like to publish both right now?
Once you publish this dataset it must remain published.
Are you sure you want to republish this dataset?
Select if this is a minor or major version update.
This dataset cannot be published until RepOD is published by its administrator.
This dataset cannot be published until RepOD and are published.
Are you sure you want to deaccession? The selected version(s) will no longer be viewable by the public.
Contact person for this dataset, having substantive knowledge of the data
Please fill this out to prove you are not a robot.
